Detalles de la búsqueda
1.
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
Nephrol Dial Transplant
; 37(7): 1261-1269, 2022 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850173
2.
Targeting the Endothelin A Receptor in IgA Nephropathy.
Kidney Int Rep
; 8(11): 2198-2210, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025243
3.
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
BMJ Open Diabetes Res Care
; 9(1)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34172436
4.
Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapy.
Diabetes Care
; 38(3): 431-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25216510
5.
LX4211 therapy reduces postprandial glucose levels in patients with type 2 diabetes mellitus and renal impairment despite low urinary glucose excretion.
Clin Ther
; 37(1): 71-82.e12, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25529979
6.
Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes.
Clin Ther
; 35(3): 273-285.e7, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23433601
7.
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects.
Clin Ther
; 35(8): 1162-1173.e8, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23911260
8.
Study design and rationale of a dose-ranging trial of LX4211, a dual inhibitor of SGLT1 and SGLT2, in type 2 diabetes inadequately controlled on metformin monotherapy.
Clin Cardiol
; 36(7): 367-71, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23630033
Resultados
1 -
8
de 8
1
Próxima >
>>